| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2011) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN Prodrug |
| ATC: | L01XC12 |
| UNII: | 7XL5ISS668 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large-Cell, Anaplastic | 4 | D017728 | ClinicalTrials |
| Hodgkin Disease | 4 | D006689 | ClinicalTrials |
| Mycosis Fungoides | 3 | D009182 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Neoplasms, Germ Cell and Embryonal | 2 | D009373 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Leukemia, Mast-Cell | 2 | D007946 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Leukemia-Lymphoma, Adult T-Cell | 2 | D015459 | ClinicalTrials |
| Enteropathy-Associated T-Cell Lymphoma | 2 | D058527 | ClinicalTrials |
| Scleroderma, Diffuse | 2 | D045743 | ClinicalTrials |
| Sezary Syndrome | 2 | D012751 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 2 | D016411 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Lymphoma, T-Cell, Cutaneous | 1 | D016410 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 914088-09-8 |
| ChEMBL | CHEMBL1742994 |
| FDA SRS | 7XL5ISS668 |
| Guide to Pharmacology | 6772 |
CONTENTS